Previous 10 | Next 10 |
Microbot Medical (NASDAQ: MBOT ) -10% on self-cleaning shunt data . More news on: Microbot Medical Inc., Neurotrope, Inc., The Wendy's Company, Stocks on the move, Read more ...
Gainers : ACADIA Pharmaceuticals (NASDAQ: ACAD ) +60% . Changyou.com Limited (NASDAQ: CYOU ) +49% . Key Energy Services (NYSE: KEG ) +29% . Cesca Therapeutics (NASDAQ: KOOL ) +25% . Hovnanian Enterprises (NYSE: HOV ) +24% . Gulfport Energy Corporation (NASDAQ: GPOR ) +20% . Independe...
ACADIA Pharmaceuticals (NASDAQ: ACAD ) +76% on positive pimavanserin data . More news on: ACADIA Pharmaceuticals Inc., Changyou.com Limited, Sintx Technologies, Inc., Stocks on the move, Read more ...
Cesca Therapeutics (NASDAQ: KOOL ) and ThermoGenesis, its wholly owned device subsidiary (the "Company") has signed an exclusive, global distribution agreement in which the Company will supply its X-Series cell processing products to a life sciences distributor who will market them globall...
RANCHO CORDOVA, Calif. , Sept. 9, 2019 /PRNewswire/ -- Cesca Therapeutics Inc. (Nasdaq: KOOL), a market leader in automated cell processing and autologous cell therapies for regenerative medicine, and ThermoGenesis, its wholly owned device subsidiary (the "Company"), filed a Form 8-K last...
RANCHO CORDOVA, Calif. , Sept. 3, 2019 /PRNewswire/ -- Cesca Therapeutics Inc. (Nasdaq: KOOL), a market leader in automated cell processing and autologous cell therapies for regenerative medicine, today announced Jeff Cauble, Vice President of Finance and Principal Accounting Officer...
Cesca Therapeutics Inc. (KOOL) Q2 2019 Earnings Conference Call August 13, 2019 16:30 ET Company Participants Paula Schwartz - Managing Director, Rx Communications Chris Xu - Chairman & Chief Executive Officer Jeff Cauble - Principal Accounting Officer Conference Call Part...
Cesca Therapeutics (NASDAQ: KOOL ): Q2 GAAP EPS of -$0.47 beats by $0.13 . More news on: Cesca Therapeutics Inc., Earnings news and commentary, Stocks on the move, Healthcare stocks news, , Read more ...
RANCHO CORDOVA, Calif. , Aug. 13, 2019 /PRNewswire/ -- Cesca Therapeutics Inc. (Nasdaq: KOOL), a market leader in automated cell processing and autologous cell therapies for regenerative medicine, today announced improved financial and operating results for the second quarter e...
RANCHO CORDOVA, Calif. , Aug. 6, 2019 /PRNewswire/ -- Cesca Therapeutics Inc. (Nasdaq: KOOL), a market leader in automated cell processing and autologous cell therapies for regenerative medicine, today announced that the Company will release its financial results for the se...
News, Short Squeeze, Breakout and More Instantly...
Cesca Therapeutics Inc. Company Name:
KOOL Stock Symbol:
NASDAQ Market:
Cesca Therapeutics Inc. Website:
RANCHO CORDOVA, Calif. , Oct. 31, 2019 /PRNewswire/ -- Cesca Therapeutics Inc. (Nasdaq: KOOL), a market leader in automated cell processing for regenerative medicine, today announced that the company will change its name to ThermoGenesis Holdings, Inc. ("ThermoGenesis") in order...
RANCHO CORDOVA, Calif. , Oct. 24, 2019 /PRNewswire/ -- Cesca Therapeutics Inc. (Nasdaq: KOOL), a market leader in automated cell processing and autologous cell therapies for regenerative medicine, today announced Chris Xu , Ph.D., Chairman and Chief Executive Officer, will present a...
RANCHO CORDOVA, Calif. , Oct. 22, 2019 /PRNewswire/ -- Cesca Therapeutics Inc. (Nasdaq: KOOL), a market leader in automated cell processing and autologous cell therapies for regenerative medicine, and ThermoGenesis, its wholly owned device subsidiary, today announced that the company...